Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2025-10-03 00:00:00 ET · period of report 2025-10-02 · accession 0001539937-25-000030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-10-03 | 2025-10-02 | SUPN | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +39.3K | 1.18M | +3% | $0 |
| DM | 2025-10-03 | 2025-10-02 | SUPN | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $46.21 | -15.3K | 1.17M | -1% | -$708.2K |
| DM | 2025-10-03 | 2025-10-02 | SUPN | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | -39.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-02 | M | A | 19,320 | $0.00 | 1,192,757 | D | — | — | (F3) Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024. |
| 2 | Common | Common Stock | 2025-10-02 | F | D | 7,529 | $46.21 | 1,185,228 | D | — | — | (F2) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. |
| 3 | Common | Common Stock | 2025-10-02 | F | D | 7,796 | $46.21 | 1,173,437 | D | — | — | (F2) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. |
| 4 | Common | Common Stock | 2025-10-02 | M | A | 20,000 | $0.00 | 1,181,233 | D | — | — | (F1) Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 19, 2021. |
| 5 | Derivative | Performance Share Unit | 2025-10-02 | M | D | 20,000 | $0.00 | 0 | D | $0.00 · — to — | 20,000 Common Stock | (F4) On February 19, 2021, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on April 30, 2021. |
| 6 | Derivative | Performance Share Units | 2025-10-02 | M | D | 19,320 | $0.00 | 0 | D | $0.00 · — to — | 19,320 Common Stock | (F5) On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. |